Erawat Pharma Profile
Key Indicators
- Authorised Capital ₹ 6.95 Cr
- Paid Up Capital ₹ 6.75 Cr
- Company Age 31 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 50.00 Cr
- Satisfied Charges ₹ 29.78 Cr
- Revenue Growth 36.64%
- Profit Growth 228.90%
- Ebitda 149.33%
- Net Worth 59.28%
- Total Assets 38.52%
About Erawat Pharma
Erawat Pharma Limited (EPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 01 March 1993 and has a history of 31 years and 11 months. Its registered office is in Indore, Madhya Pradesh, India.
The Corporate was formerly known as Erawat Pharma Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.95 Cr and a paid-up capital of Rs 6.75 Cr.
The company currently has active open charges totaling ₹50.00 Cr. The company has closed loans amounting to ₹29.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hemchandra Jain, Meena Jain, Amit Jain, and Four other members serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U02423MP1993PLC007538
-
Company No.
007538
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
01 Mar 1993
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
What products or services does Erawat Pharma Limited offer?
Erawat Pharma Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Pharmaceutical Excipients, Pharma Raw Material.
Who are the key members and board of directors at Erawat Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemchandra Jain
|
Managing Director | 01-Mar-1993 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Meena Jain
|
Director | 15-Jun-2021 | Current |
|
Amit Jain
|
Whole-Time Director | 01-Oct-2018 | Current |
|
Abhijeet Jain
|
Whole-Time Director | 01-Oct-2018 | Current |
|
Abhishek Jain
|
Whole-Time Director | 11-Jul-2003 | Current |
|
Devindar Sodhi
|
Director | 30-Apr-1997 | Current |
|
Vasant Solanki
|
Director | 16-Aug-1994 | Current |
Financial Performance of Erawat Pharma.
Erawat Pharma Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 36.64% increase. The company also saw a substantial improvement in profitability, with a 228.9% increase in profit. The company's net worth Soared by an impressive increase of 59.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Erawat Pharma?
In 2022, Erawat Pharma had a promoter holding of 80.70% and a public holding of 19.30%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Erawat Engineering Pvt LtdHemchandra Jain and Meena Jain are mutual person
-
Dashmesh Sonail Healthcare Private LimitedDevindar Sodhi is a mutual person
-
Anant Machines & Equipment Private LimitedHemchandra Jain and Meena Jain are mutual person
-
Erawat Vegcap Private Limited
Hemchandra Jain, Meena Jain and 3 more are mutual person
-
Jhanjhari Sons Leasing And Investment Pvt Ltd
Meena Jain and Abhishek Jain are mutual person
-
Anant Formulations Private Limited
Meena Jain is a mutual person
Charges (Loans)
₹50.00 Cr
₹29.78 Cr
Charges Breakdown by Lending Institutions
- Others : 47.90 Cr
- Sidbi : 2.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Nov 2024 | Sidbi | ₹8.18 M | Open |
| 26 Feb 2024 | Others | ₹8.91 M | Open |
| 22 Nov 2023 | Sidbi | ₹1.28 Cr | Open |
| 13 Apr 2023 | Others | ₹8.24 Cr | Open |
| 21 Oct 2022 | Others | ₹4.27 M | Open |
How Many Employees Work at Erawat Pharma?
Erawat Pharma has a workforce of 175 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Erawat Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Erawat Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
